Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-04-14, Stock:PFE, The news for the past five days is as follows:
2021-04-07: NEWS1: We will fight in protecting the right to vote: Michigan Lt. Governor.NEWS2: Coronavirus: 'We are seeing so many younger patients'.NEWS3: COVID-19 mitigation is the ‘most effective weapon’ to avoid fourth wave: Doctor.NEWS4: NIH Starts Study On Allergic Reactions Risk To Pfizer/BioNTech, Moderna COVID-19 Vaccines.NEWS5: White House won’t support ‘vaccine passports’: Psaki.NEWS6: Pfizer’s Xeljanz Faces Canadian Review Amid More Scrutiny of JAK Inhibitors.NEWS7: UPDATE 1-U.S. begins study on allergic reaction risk in Moderna, Pfizer vaccines.NEWS8: Pfizer's Xeljanz Under Health Canada's Scrutiny For Safety Risks.NEWS9: Pfizer says FDA review time for dermatitis drug candidate has been extended.NEWS10: UPDATE 2-U.S. FDA extends review of Pfizer's experimental skin disease drug.NEWS11: This Vaccine Maker May Be Next to Go After the Kids' Market.NEWS12: Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis.NEWS13: AstraZeneca vaccine's causal link to blood clots not proven, says European Medicines Agency.
2021-04-08: NEWS1: UPDATE 6-Australia doubles Pfizer vaccine order as Astra clotting worries upend rollout.NEWS2: Australian PM meets state and territory leaders under pressure from vaccine shift.NEWS3: Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus.NEWS4: Fauci: new Covid-19 cases are at a disturbing level, U.S. is primed for a surge.NEWS5: Study shows wearables could detect COVID-19 earlier.NEWS6: WRAPUP 2-AstraZeneca woes grow as Australia, Philippines, African Union curb COVID-19 shots.NEWS7: COVID-19 vaccinations are ‘extraordinarily safe’: Doctor.NEWS8: Pfizer (PFE) Dermatitis JAK Inhibitor NDA Review Gets Delayed.NEWS9: Why Didn't Pfizer and BioNTech Stocks Soar After Their COVID Vaccine Achieved 100% Efficacy in Kids?.NEWS10: Oxford scientists behind COVID-19 vaccine set for multimillion pound payday.NEWS11: UPDATE 1-Britons can be confident in vaccine monitoring, health secretary says.NEWS12: Australia backs Pfizer virus vaccine over AstraZeneca for under-50s.
2021-04-09: NEWS1: "A big hit to the vaccine campaign": Doctor on Johnson & Johnson's vaccine delivery plunge.NEWS2: 2 More Biotechs Hit the Market Today. Here’s How They Did..NEWS3: How A Pfizer Cancer Drug Pact Launched Celcuity Stock Into A Breakout.NEWS4: What Can BioNTech Do for an Encore?.NEWS5: Pfizer Has a Lumpy Growth Story, But It’s a Promising Investment.NEWS6: European Union Looks To Buy 1.8B Pfizer-BioNTech COVID-19 Vaccine Doses From 2022: Reuters.NEWS7: Pfizer asks FDA to expand COVID-19 vaccine authorization to include 12- to 15-year-olds.NEWS8: Pfizer’s vaccine EUA expansion request is ‘extremely welcomed’: Doctor.NEWS9: Pfizer requests FDA expand authorization to include 12 to 15 year olds.NEWS10: UPDATE 3-Pfizer, BioNTech seek U.S. emergency nod for COVID-19 vaccine in adolescents.NEWS11: Biotech Has Dominated the IPO Market. Two More Started Trading Today..NEWS12: ‘The Michigan spike is something we should be nervous about’: Doctor.NEWS13: Higher-Than-Expected PPI in March.NEWS14: Pfizer Seeks Vaccine Authorization for Children Ages 12 to 15.NEWS15: UPDATE 2-EU seeks new contract with Pfizer/BioNTech for up to 1.8 bln vaccines from 2022 -EU source.NEWS16: Europe probes possible blood clot link with Johnson & Johnson COVID vaccine.NEWS17: Pharma Stock Roundup: FDA Decision Delays for PFE, LLY, ABBV, AZN Vaccine Woes.NEWS18: BioNTech, Pfizer Gain As EU, Australia Seek More Covid Vaccine Doses.NEWS19: J&J Vaccine Dose Allocations Will Drop Next Week. It Won’t Have an Immediate Effect on Availability..NEWS20: CORRECTED-EU preparing orders for 1.8 bln vaccine booster shots - Die Welt.NEWS21: Celcuity Stock Moves Higher After Licensing Pact With Pfizer For Gedatolisib In Breast Cancer.NEWS22: This Is Why Moderna Is a Great Stock to Buy Right Now.NEWS23: 3 Robinhood Stocks That Are Ridiculously Cheap.NEWS24: Australia says it will buy 20 million extra doses of Pfizer COVID-19 vaccine in pivot away from AstraZeneca.NEWS25: Australia to purchase 20 million more doses of Pfizer's COVID-19 vaccine - PM.NEWS26: Pfizer and BioNTech seek US vaccine authorisation for adolescents.
2021-04-12: NEWS1: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS2: COVID SCIENCE-Autoimmune-disease drugs may reduce vaccine response; antibody treatments ineffective vs Brazil variant.NEWS3: ‘Unvaccinated folks’ are driving coronavirus surges as American society slowly reopens.NEWS4: South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report.NEWS5: I’d still trust vaccines to suppress emergence of more variants: Doctor.NEWS6: Brussels faces soaring costs for Pfizer's Covid vaccine.NEWS7: Doctor on vaccine push: 'These vaccines work extremely well and that’s something to celebrate'.NEWS8: One Strain Better Than Others at Infecting People Dosed With Pfizer Vaccine, Study Shows.NEWS9: Stock Market News for Apr 12, 2021.NEWS10: Bulgarian PM reveals price for EU's new vaccine contract with Pfizer.NEWS11: Top official admits China’s COVID-19 vaccines have low effectiveness.NEWS12: UPDATE 1-Brazil, Mexico, Philippines among those due to get Pfizer shots from COVAX in Q2 - statement.NEWS13: Brazil, Mexico, Philippines among those due to get Pfizer shots from COVAX in Q2 - statement.NEWS14: Celcuity (CELC) Soars on Agreement With Pfizer & Study Data.NEWS15: Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study Evaluating Contraceptive Efficacy of Once-Daily Relugolix Combination Tablet.NEWS16: Pfizer's About to Cut Its Dividend: What You Need to Know.NEWS17: UPDATE 1-Japan begins COVID-19 shots for over 65s as fourth infection wave looms.NEWS18: Japan begins COVID-19 shots for over 65s as fourth infection wave looms.NEWS19: Top China official admits its COVID-19 vaccines have low effectiveness.
2021-04-13: NEWS1: UK trial on switching COVID-19 vaccines adds Moderna and Novavax shots.NEWS2: S&P 500 Hits Another New All-Time High.NEWS3: Johnson & Johnson Vaccine Pause: What to Know If You Got or Scheduled the Shot.NEWS4: More likely to be struck by lightning? Americans weigh risk of J&J vaccine.NEWS5: Myovant (MYOV), Pfizer Start Dosing in Relugolix Combo Study.NEWS6: Pfizer to deliver 10% more doses to U.S. by end of May: CEO.NEWS7: Pfizer ramps up COVID-19 vaccine production for the U.S., CEO says.NEWS8: Biden says U.S. has enough vaccines for 'every single' American.NEWS9: Jim Cramer: Johnson & Johnson? Moderna and Pfizer Can Do the Job.NEWS10: Doctor on J&J vaccine pause: CDC is letting the public know they are taking any side effect seriously.NEWS11: UPDATE 1-U.S. has more than enough vaccine to maintain pace of inoculations as  J&J shot paused.NEWS12: Pfizer Expanding Production of COVID-19 Vaccine by 10%.NEWS13: Johnson & Johnson vaccine setback sends shares of stay-at-home stocks like Zoom higher.NEWS14: White House says J&J pause won’t slow vaccine rollout.NEWS15: Doctor on J&J vaccine: 'We’re talking about one in a million for these clots'.NEWS16: Johnson & Johnson pause ‘will not have a significant impact on our vaccination plan,’ White House says.NEWS17: How COVID-19 transformed the biotech industry.NEWS18: Consumer Price Index Rise 0.6%.NEWS19: CPI +0.6%: Higher, but Not Scary; JNJ Vax on Hold?.NEWS20: Moderna, BioNTech stocks surge after regulators halt use of J&J vaccine.NEWS21: Pfizer to pursue bringing COVID-19 vaccine to India after import relaxation.NEWS22: Stock market reaction to J&J vaccine pause is ‘pretty modest’: economist.NEWS23: FDA, CDC recommend pause in Johnson & Johnson COVID-19 vaccine.NEWS24: India wants Pfizer, Moderna, Johnson & Johnson to seek licence for COVID-19 vaccines soon - government official.NEWS25: A Short Delay Is Still Bad News for AbbVie.NEWS26: An Israeli study says a COVID-19 variant can still infect vaccinated people — here’s what Fauci says the research means.NEWS27: White House Says J&J Vaccine Pause Won't Deter Rollout.NEWS28: A Surprising Vaccine Rival May Upset the Dreams of Anyone Holding Moderna and Pfizer Stock.NEWS29: Here's the Biggest Challenge Pfizer Faces Right Now.NEWS30: Will Worse Side Effects for Moderna's Vaccine Boost Pfizer's Fortunes?.NEWS31: Vaccine Stocks Checkup: Johnson & Johnson COVID-19 Vaccine Paused.NEWS32: 2 Stocks That Are Perfect to Buy Now and Hold Until Retirement.NEWS33: UPDATE 1-Australia reports second Astrazeneca blood clot case, vaccine rollout steady.NEWS34: Australia won’t be buying Johnson & Johnson COVID-19 vaccine.

Answer: Rise